World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 67 2652 2442 1268 1157 193 18767

Mark K. Slifka publications per year

The chart shows the history of publications by Mark K. Slifka between 1995 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Mark K. Slifka published across 31 years, from 1995 to 2025, averaging 6.7 papers a year. Output peaked at 13 publications in 2021. 12 of the 209 publications appeared in the last two years.

No. of publications
5 10
Bar chart. Horizontal axis: year, 1995 to 2025. Vertical axis: number of publications, 0 to 13. Peak 13 publications in 2021. 1995: 2 publications 1996: 5 publications 1997: 5 publications 1998: 5 publications 1999: 4 publications 2000: 8 publications 2001: 6 publications 2002: 6 publications 2003: 4 publications 2004: 9 publications 2005: 6 publications 2006: 10 publications 2007: 11 publications 2008: 7 publications 2009: 5 publications 2010: 5 publications 2011: 8 publications 2012: 7 publications 2013: 7 publications 2014: 10 publications 2015: 5 publications 2016: 7 publications 2017: 5 publications 2018: 4 publications 2019: 5 publications 2020: 9 publications 2021: 13 publications 2022: 10 publications 2023: 9 publications 2024: 3 publications 2025: 9 publications
1995 2025

209 publications in total across all disciplines

View publications per year as a table
Mark K. Slifka: publications per year, 1995 to 2025
Year Publications
1995 2
1996 5
1997 5
1998 5
1999 4
2000 8
2001 6
2002 6
2003 4
2004 9
2005 6
2006 10
2007 11
2008 7
2009 5
2010 5
2011 8
2012 7
2013 7
2014 10
2015 5
2016 7
2017 5
2018 4
2019 5
2020 9
2021 13
2022 10
2023 9
2024 3
2025 9
Total 209
Download as CSV

Mark K. Slifka publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Mark K. Slifka sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 192–201 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 193 publications — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187 193
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Mark K. Slifka D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Mark K. Slifka sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 66–67 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 67 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167 67
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Mark K. Slifka is affiliated with the Oregon National Primate Research Center in the United States. Their research primarily spans the field of Medicine, with a particular focus on Infectious Diseases, Epidemiology, and Molecular Biology. Additional areas of study include Public Health, Environmental and Occupational Health, as well as Oncology.

The scientist has produced significant work related to a variety of topics, including:

  • Mosquito-borne diseases and control
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Gut microbiota and health
  • Viral Infections and Outbreaks Research
  • Viral gastroenteritis research and epidemiology
  • Viral Infections and Vectors

Among recent publications with Mark K. Slifka as an author or co-author, notable papers include:

  • Is presymptomatic spread a major contributor to COVID-19 transmission? (2020, Nature Medicine)
  • Growth faltering regardless of chronic diarrhea is associated with mucosal immune dysfunction and microbial dysbiosis in the gut lumen (2021, Mucosal Immunology)
  • Consumptive coagulopathy of severe yellow fever occurs independently of hepatocellular tropism and massive hepatic injury (2020, Proceedings of the National Academy of Sciences)
  • Incidence of Tetanus and Diphtheria in Relation to Adult Vaccination Schedules (2020, Clinical Infectious Diseases)
  • Polygenic prediction of atopic dermatitis improves with atopic training and filaggrin factors (2021, Journal of Allergy and Clinical Immunology)

Frequent collaborators in their research include:

  • Archana Thomas
  • Lina Gao
  • Ilhem Messaoudi
  • Hans-Peter Raué
  • Ian J. Amanna

Mark K. Slifka has published regularly in several academic venues, with multiple contributions to:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Allergy and Clinical Immunology
  • Clinical Infectious Diseases
  • PLoS Pathogens
  • The Journal of Immunology

Best Publications

  • Humoral immunity due to long-lived plasma cells

    Mark K Slifka;Rustom Antia;Jason K Whitmire;Rafi Ahmed

  • Duration of humoral immunity to common viral and vaccine antigens.

    Ian J. Amanna;Nichole E. Carlson;Mark K. Slifka

  • Duration of antiviral immunity after smallpox vaccination

    Erika Hammarlund;Matthew W Lewis;Scott G Hansen;Lisa I Strelow

  • The many important facets of T-cell repertoire diversity

    Janko Nikolich-Žugich;Mark K. Slifka;Ilhem Messaoudi

  • Clinical implications of dysregulated cytokine production

    M K Slifka;J L Whitton

  • Long-Lived Plasma Cells Are Contained within the CD19(-)CD38(hi)CD138(+) Subset in Human Bone Marrow.

    Jessica L. Halliley;Jessica L. Halliley;Christopher M. Tipton;Jane Liesveld;Alexander F. Rosenberg

  • Functional avidity maturation of CD8 + T cells without selection of higher affinity TCR

    Mark K. Slifka;Mark K. Slifka;J. Lindsay Whitton

  • Bone marrow is a major site of long-term antibody production after acute viral infection

    Mark K. Slifka;Mehrdad Matloubian;Rafi Ahmed

  • Mechanisms that determine plasma cell lifespan and the duration of humoral immunity

    Ian J. Amanna;Mark K. Slifka

  • Rapid on/off cycling of cytokine production by virus-specific CD8 + T cells

    Mark K. Slifka;Fernando Rodriguez;J. Lindsay Whitton

  • Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox

    Erika Hammarlund;Matthew W Lewis;Shirley V Carter;Ian Amanna

  • Long-lived plasma cells: a mechanism for maintaining persistent antibody production

    Mark K Slifka;Rafi Ahmed

  • NK Markers Are Expressed on a High Percentage of Virus-Specific CD8+ and CD4+ T Cells

    Mark K. Slifka;Robb R. Pagarigan;J. Lindsay Whitton

  • Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity.

    Hao Shen;Mark K. Slifka;Mehrdad Matloubian;Eric R. Jensen

  • Contributions of humoral and cellular immunity to vaccine-induced protection in humans.

    Ian J. Amanna;Mark K. Slifka

  • Immunity and immunological memory following smallpox vaccination.

    Ian J. Amanna;Mark K. Slifka;Shane Crotty

  • Regulation of innate CD8+ T-cell activation mediated by cytokines

    Bailey E. Freeman;Erika Hammarlund;Hans Peter Raué;Mark K. Slifka

  • Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus Infections

    Iuliia Gilchuk;Pavlo Gilchuk;Pavlo Gilchuk;Gopal Sapparapu;Rebecca Lampley

  • Cell Cycle Status Affects Coxsackievirus Replication, Persistence, and Reactivation In Vitro

    Ralph Feuer;Ignacio Mena;Robb Pagarigan;Mark K. Slifka

  • Activated and memory CD8+ T cells can be distinguished by their cytokine profiles and phenotypic markers.

    Mark K. Slifka;J. Lindsay Whitton

  • How do viral infections predispose patients to bacterial infections

    Carol Beadling;Mark K Slifka

Frequent Co-Authors

Rafi Ahmed
Rafi Ahmed Emory University
Jon M. Hanifin
Jon M. Hanifin Oregon Health & Science University
J. Lindsay Whitton
J. Lindsay Whitton Scripps Research Institute
David C. Parker
David C. Parker Oregon Health & Science University
Klaus Früh
Klaus Früh Oregon Health & Science University
Jason K. Whitmire
Jason K. Whitmire University of North Carolina at Chapel Hill
Michael S. Diamond
Michael S. Diamond Washington University in St. Louis
James E. Crowe
James E. Crowe Vanderbilt University Medical Center
Merlin L. Robb
Merlin L. Robb Walter Reed Army Institute of Research
Jonah B. Sacha
Jonah B. Sacha Oregon Health & Science University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can broaden career opportunities. Many students consider advancing their education through programs like the cheapest pmhnp programs online, which offer specialized training in psychiatric nursing alongside foundational biological sciences.

Understanding compensation trends is essential when planning a career path. A doctorate in nursing salary varies by location, emphasizing the importance of research when selecting where to study or practice.

For nurses aiming to specialize, transitioning from a family nurse practitioner to an acute care nurse practitioner is a strategic move. Guidance on this process can be found in detailed resources like fnp to acnp, helping professionals shift toward urgent and critical care environments.

Accelerated learning options also exist for those eager to enter the field quickly. Many students benefit from an accelerated nurse practitioner program, which condenses essential coursework without sacrificing quality or accreditation.

Best Scientists Citing Mark K. Slifka

Trending Scientists

Recently Published Articles